PTX 5.26% 4.0¢ prescient therapeutics limited

Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-3

  1. 7,761 Posts.
    lightbulb Created with Sketch. 3304
    Well, this bodes well for a mixed-label pivotal study. I wonder whether our application for ODD in Europe will be amended to include CTCL. At least now, the team won't have to make the difficult decision as to which TCL gets dropped from further study. This is great news! smile.png
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.002(5.26%)
Mkt cap ! $30.60M
Open High Low Value Volume
3.9¢ 4.0¢ 3.8¢ $52.84K 1.371M

Buyers (Bids)

No. Vol. Price($)
1 25000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 84039 2
View Market Depth
Last trade - 12.49pm 01/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.